Canada based Atrial Fibrillation Clinical Trials & Research Studies Near You (Updated 8/25)

Surgical Ablation of AF Efficacy Trial

NCT05434819

Recruiting

SAFE is an international multicentre RCT of concomitant surgical atrial fibrillation (AF) ablation in patients with paroxysmal or persistent AF undergoing cardiac surgery.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

02/27/2025

Locations: Hamilton General Hospital, Hamilton, Ontario

Conditions: Atrial Fibrillation, Heart Failure

Register for Updates

Learn More ›

Amplatzer Amulet LAAO Vs. NOAC

NCT04226547

Recruiting

The objective of this trial is to evaluate the safety and effectiveness of the Amulet LAA occluder compared to NOAC therapy in patients with non-valvular AF at increased risk for ischemic stroke and who are recommended for long-term NOAC therapy. The clinical investigation is a prospective, randomized, multicenter active control worldwide trial. Subjects will be randomized in a 1:1 ratio between the Amulet LAA occlusion device ("Device Group") and a commercially available NOAC medication ("Cont... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

02/25/2025

Locations: University Hospital - Univ. of Alabama at Birmingham (UAB), Birmingham, Alabama +131 locations

University Hospital - Univ. of Alabama at Birmingham (UAB), Birmingham, Alabama

Heart Center Research, LLC, Huntsville, Alabama

Arizona Cardiovascular Research Center, Phoenix, Arizona

Tucson Medical Center, Tucson, Arizona

Arrhythmia Research Group, Jonesboro, Arkansas

UAMS Medical Center, Little Rock, Arkansas

Scripps Health, La Jolla, California

Kaiser Permanente Los Angeles Medical Center, Los Angeles, California

Huntington Memorial Hospital, Pasadena, California

Mercy Medical Group - Cardiology, Sacramento, California

University of California at San Diego (UCSD) Medical Center, San Diego, California

South Denver Cardiology Associates PC, Littleton, Colorado

MedStar Washington Hospital Center, Washington, District of Columbia

AdventHealth Florida Cardiology - Altamonte Springs, Altamonte Springs, Florida

St. Vincent's Medical Center, Jacksonville, Florida

Baptist Medical Center, Jacksonville, Florida

AdventHealth Florida Cardiology - Lake Mary, Lake Mary, Florida

NCH Healthcare System, Naples, Florida

AdventHealth Orlando, Orlando, Florida

AdventHealth Florida Cardiology - Oviedo, Oviedo, Florida

Sarasota Memorial Hospital, Sarasota, Florida

Piedmont Heart Institute, Atlanta, Georgia

Emory University Hospital, Atlanta, Georgia

Northside Hospital, Atlanta, Georgia

St. Joseph's Hospital, Atlanta, Georgia

Northside Hospital (CardioVascular Group Lawrenceville), Lawrenceville, Georgia

Northwestern Memorial Hospital, Chicago, Illinois

Rush University Medical Center, Chicago, Illinois

Central DuPage Hospital, Winfield, Illinois

Lutheran Hospital of Indiana, Fort Wayne, Indiana

St. Vincent Hospital, Indianapolis, Indiana

Kansas University Medical Center, Kansas City, Kansas

Kansas City Cardiac Arrhythmia Research Foundation, Overland Park, Kansas

Overland Park Mid America Cardiology, Overland Park, Kansas

Via Christi Regional Medical Center - St. Francis Campus, Wichita, Kansas

Baptist Health Lexington, Lexington, Kentucky

Our Lady of the Lake Physician Group, Baton Rouge, Louisiana

Cardiovascular Institute of the South, Houma, Louisiana

MedStar Union Memorial Hospital, Baltimore, Maryland

Tufts Medical Center, Boston, Massachusetts

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Spectrum Health Butterworth Hospital, Grand Rapids, Michigan

VA Medical Center Minneapolis, Minneapolis, Minnesota

St. Cloud Hospital - Central MN Heart Clinic, Saint Cloud, Minnesota

Jackson Heart Clinic, Jackson, Mississippi

Bryan Heart, Lincoln, Nebraska

CHI Health Creighton University Medical Center-Bergan Mercy, Omaha, Nebraska

Cooper University Hospital, Camden, New Jersey

New Mexico Heart Institute, Albuquerque, New Mexico

South Shore University Hospital-Northwell, Bay Shore, New York

Buffalo General Hospital, Buffalo, New York

Mount Sinai Hospital, New York, New York

New York Presbyterian Hospital/Cornell University, New York, New York

Staten Island University Hospital Northwell, Staten Island, New York

Mission Health & Hospitals, Asheville, North Carolina

NC Heart & Vascular Research, Raleigh, North Carolina

TriHealth Bethesda North Hospital, Cincinnati, Ohio

The Cleveland Clinic Foundation, Cleveland, Ohio

Hightower Clinical, Oklahoma City, Oklahoma

Integris Baptist Medical Center, Oklahoma City, Oklahoma

Oklahoma Heart Institute at Utica, Tulsa, Oklahoma

Pinnacle Health System, Harrisburg, Pennsylvania

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

WellSpan Health, York, Pennsylvania

Roper Hospital, Charleston, South Carolina

Sanford USD Medical Center, Sioux Falls, South Dakota

Erlanger Medical Center, Chattanooga, Tennessee

Tennova Healthcare-Turkey Creek Medical Center, Knoxville, Tennessee

Vanderbilt Heart & Vascular Institute, Nashville, Tennessee

Texas Cardiac Arrhythmia, Austin, Texas

Baylor All Saints Medical Center at Fort Worth, Forth Worth, Texas

Park Plaza Hospital, Houston, Texas

CHI St. Luke's Health Baylor College of Medicine Med. Ctr., Houston, Texas

Memorial Hermann Hospital, Houston, Texas

The Methodist Hospital, Houston, Texas

Memorial Katy Cardiology Associates, Houston, Texas

The Heart Hospital Baylor Plano, Plano, Texas

Methodist Texsan Hospital, San Antonio, Texas

Heart Rhythm Associates, Shenandoah, Texas

Sentara Norfolk General Hospital, Norfolk, Virginia

Monongalia General Hospital, Morgantown, West Virginia

Medical College of Wisconsin, Milwaukee, Wisconsin

Royal Adelaide Hospital, Adelaide, South Australia

Fiona Stanley Hospital, Murdoch, Western Australia

Royal Melbourne Hospital - City Campus, Parkville, Not set

Ottawa Heart Institute, Ottawa, Ontario

Institut de Cardiologie de Montreal (Montreal Heart Inst.), Montréal, Not set

CHUM, Montréal, Not set

Vancouver General Hospital (U of BC), Vancouver, Not set

Fakultni nemocnice Kralovske Vinohrady, Prague, Not set

Nemocnice Na Homolce, Prague, Not set

Skejby University Hospital, Arhus, Not set

Rigshospitalet, Copenhagen, Not set

CHU Gabriel Montpied, Clermont-Ferrand, Not set

Hopital Henri Mondor, Créteil, Not set

Institute Cardio. Paris-Sud - Institut Jacques Cartier, Massy, Not set

Mutualiste Montsouris, Paris, Not set

Hopital Haut Leveque, Pessac, Not set

Universitätsmedizin Berlin - Campus Benjamin Franklin (CBF), Berlin, Brandenburg

Universitätsklinikum Schleswig-Holstein - Campus Lübeck, Lübeck, Schleswig-Holstein

Segeberger Kliniken GmbH, Bad Segeberg, Not set

St. Marien-Hospital-Bonn, Bonn, Not set

Cardioangiologisches Centrum am Bethanien Krankenhaus, Frankfurt, Not set

Klinikum der Justus-Liebig-Universität, Gießen, Not set

Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Not set

Internistisches Klinikum München SUD, Munich, Not set

Helios Klinikum Siegburg, Siegburg, Not set

Prince of Wales Hospital, Hong Kong, Not set

Queen Elizabeth Hospital, Hong Kong, Not set

The University of Hong Kong (Queen Mary Hospital), Hong Kong, Not set

Fondazione Toscana Gabriele Monasterio, Massa, Not set

Ospedale San Raffaele, Milano, Not set

Toyohashi Heart Center, Toyohashi, Aichi

Chiba University, Chiba-shi, Chiba

Kokura Memorial Hospital, Kitakyushu, Fukuoka

University of Tsukuba Hospital, Tsukuba, Ibaraki

Shonan Kamakura General Hospital, Kamakura, Kanagawa

Sendai Kousei Hospital, Sendai, Miyagi

Kurashiki Central Hospital, Kurashiki-shi, Okayama

Toho University Ohashi Medical Center, Meguro-ku, Tokyo

Institute of Science Tokyo Hospital, Tokyo, Not set

Vilnius University Hospital Santariskiu Klinikos, Vilnius, Not set

St. Antonius Ziekenhuis, Nieuwegein, Not set

Slaskie Centrum Chorob Serca, Zabrze, Not set

Centralny Szpital Kliniczny Uniwersytetu Medycznego w Lodzi, Łódź, Not set

Hospital Clinico San Carlos, Madrid, Community of Madrid

Hospital de la Santa Creu I Sant Pau, Barcelona, Not set

Hospital Clinic I Provincial de Barcelona, Barcelona, Not set

Hospital Universitario de Salamanca, Salamanca, Not set

Center Inselspital Bern, Bern, Not set

Stadtspital Triemli, Zürich, Not set

The Royal Sussex County Hospital, Brighton, Not set

Conditions: Atrial Fibrillation, Stroke, Bleeding

Register for Updates

Learn More ›

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

NCT04045665

Recruiting

The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop new-onset post-operative atrial fibrillation (POAF) after isolated coronary artery bypass graft (CABG) surgery. All patients with a qualifying POAF event, who decline randomization, will be offered the option of enrollment in a parallel registry that captures their ba... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

02/05/2025

Locations: CHI St. Vincent, Arkansas, Little Rock, Arkansas +95 locations

CHI St. Vincent, Arkansas, Little Rock, Arkansas

University of Southern California, Los Angeles, California

Cedars-Sinai Medical Center, Los Angeles, California

Stanford University, Stanford, California

Medical Center of Aurora, Aurora, Colorado

Western Connecticut Hospital Systems, Danbury, Connecticut

Yale Medicine, New Haven, Connecticut

MedStar Washington Hospital Center, Washington, District of Columbia

Emory University, Atlanta, Georgia

Piedmont Healthcare Inc., Atlanta, Georgia

Lutheran Medical Center, Fort Wayne, Indiana

Indiana University, Indianapolis, Indiana

Ascension St. Vincent, Indianapolis, Indiana

Ochsner Clinic, New Orleans, Louisiana

Maine Medical Center, Portland, Maine

University of Maryland, Baltimore, Maryland

Johns Hopkins, Baltimore, Maryland

Suburban Hospital, Bethesda, Maryland

Massachusetts General Hospital, Boston, Massachusetts

Brigham and Women's Hospital, Boston, Massachusetts

Boston Medical Center, Boston, Massachusetts

Baystate Health, Springfield, Massachusetts

University of Michigan, Ann Arbor, Michigan

Mayo Clinic, Rochester, Minnesota

Mid America Health Institute, Kansas City, Missouri

Washington University School of Medicine, Saint Louis, Missouri

Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire

Jersey Shore University Medical Center, Neptune, New Jersey

Montefiore Medical Center, Bronx, New York

Northwell Health System, Great Neck, New York

The Mount Sinai Hospital, New York, New York

Columbia University Medical Center, New York, New York

Duke University, Durham, North Carolina

East Carolina University, Greenville, North Carolina

WakeMed, Raleigh, North Carolina

Cleveland Clinic Foundation, Cleveland, Ohio

Ohio State University Medical Center, Columbus, Ohio

Ascension St. John, Tulsa, Oklahoma

University of Pittsburgh Medical Center, Hermitage, Pennsylvania

University of Pennsylvania, Philadelphia, Pennsylvania

Allegheny Health Network, Pittsburgh, Pennsylvania

Baylor College of Medicine, Houston, Texas

Baylor Research Institute, Plano, Texas

Intermountain CV Research, Murray, Utah

University of Utah, Salt Lake City, Utah

University of Vermont, Burlington, Vermont

University of Virginia Health System, Charlottesville, Virginia

Inova Health, Falls Church, Virginia

West Virginia University, Morgantown, West Virginia

University of Wisconsin, Madison, Wisconsin

University of Alberta Hospital, Edmonton, Alberta

London Health Sciences Centre, London, Ontario

Sunnybrook Hospital, Toronto, Ontario

Montreal Heart Institute, Montreal, Quebec

Centre Hospitalier de l'Université de Montréal, Montreal, Quebec

Hôpital du Sacré-Cœur de Montréal, Montreal, Quebec

University of Ottawa Heart Institute, Ottawa, Not set

Hôpital Laval, Quebec, Not set

Toronto General Hospital, Toronto, Not set

University Heart Center Hamburg, Berlin, Brandenburg

Heart Center Leipzig, Berlin, Brandenburg

University Medical Center Göttingen, Göttingen, Lower Saxony

University Medical Center Jena, Jena, Thuringia

Clinic Bad Neustadt - Medical Center for Heart and Vascular Diseases, Bad Neustadt An Der Saale, Not set

HDZ-NRW Bad Oeynhausen, Bad Oeynhausen, Not set

Charité Berlin - Benjamin Franklin Campus, Berlin, Not set

Charité Berlin - Rudolf Virchow Campus, Berlin, Not set

German Heart Center Berlin, Berlin, Not set

University Hospital Bonn, Bonn, Not set

Medical Center Braunschweig, Braunschweig, Not set

Heinrich Heine University Düsseldorf, Düsseldorf, Not set

Frankfurt University Hospital, Frankfurt, Not set

University Medical Center Frankfurt, Frankfurt, Not set

Heart Center, University of Freiburg, Freiburg, Not set

University Medical Center Heidelberg, Heidelberg, Not set

University Medical Center Schleswig-Holstein Kiel, Kiel, Not set

University Medical Center Schleswig-Holstein Lübeck, Lübeck, Not set

University Hospital Magdeburg, Magdeburg, Not set

German Heart Center Munich, Munich, Not set

Medical Center of the Ludwig-Maximilians-University Munich, Munich, Not set

Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, England

Barts Health NHS Trust, London, England

Imperial College Healthcare NHS Trust, London, England

Royal Wolverhampton NHS Trust, Wolverhampton, England

Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, Not set

University Hospitals Bristol NHS Foundation Trust, Bristol, Not set

Royal Papworth Hospital NHS Foundation Trust, Cambridge, Not set

Hull University Teaching Hospitals NHS Trust, Cottingham, Not set

University Hospitals of Leicester NHS Trust, Leicester, Not set

South Tees Hospitals NHS Foundation Trust, Middlesbrough, Not set

Nottingham University Hospitals NHS Trust, Nottingham, Not set

Oxford University Hospitals NHS Foundation Trust, Oxford, Not set

University Hospitals Plymouth NHS Trust, Plymouth, Not set

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, Not set

University Hospital Southampton NHS Foundation Trust, Southampton, Not set

University Hospitals Sussex NHS Foundation Trust, Worthing, Not set

Conditions: Atrial Fibrillation, Stroke, Bleeding

Register for Updates

Learn More ›

Reversal of Atrial Substrate to Prevent Atrial

NCT03682991

Recruiting

A multi-center, randomized trial to examine the effect of aggressive risk factor control and arrhythmia trigger-based intervention on recurrence of atrial fibrillation.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

12/13/2024

Locations: Foothills Hospital, Calgary, Alberta +16 locations

Conditions: Atrial Fibrillation

Register for Updates

Learn More ›

DETECTion of PeriOperative Atrial Fibrillation After Noncardiac Surgery

NCT06519747

Recruiting

This is a multicentre prospective cohort study where patients will receive up to 14 days of continuous ECG monitoring by wearing a portable monitoring device, starting within 72 hours after noncardiac surgery.

Gender:

ALL

Ages:

Between 18 years and 120 years

Trial Updated:

11/05/2024

Locations: Hamilton General Hospital, Hamilton, Ontario +5 locations

Conditions: Atrial Fibrillation, Atrial Flutter

Register for Updates

Learn More ›

Early Atrial Fibrillation Ablation for Stroke Prevention in Patients with High Comorbidity Burden (EASThigh-AFNET 11)

NCT06324188

Recruiting

EASThigh-AFNET 11 is an international, prospective, randomized, open, blinded endpoint assessment, multicenter trial (Treatment Strategy trial). The objective of EASThigh-AFNET 11 is to investigate whether early atrial fibrillation ablation in patients with atrial fibrillation (AF) and a high comorbidity burden (CHA2DS2-VASc ≥4) reduces cardiovascular events (stroke, cardiovascular death, or heart failure events) compared to usual care.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

10/15/2024

Locations: Several sites, Multiple Locations, Not set +4 locations

Conditions: Atrial Fibrillation

Register for Updates

Learn More ›

Oral Amiodarone for Acute Cardioversion of Atrial Fibrillation Study

NCT04594746

Recruiting

The investigators will seek to determine the safety and efficacy of high-dose amiodarone (2000mg), given as a single uniform oral dose, for the treatment of acute atrial fibrillation in both a hospital inpatient and ambulatory outpatient setting. The investigators will conduct a placebo-controlled randomized trial, with outcome ascertainment at 48h.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

05/15/2024

Locations: University of Calgary, Calgary, Alberta

Conditions: Atrial Fibrillation

Register for Updates

Learn More ›

QOL Improvement After Cardioversion of Persistent AF (QOL-CAFRCT)

NCT05136131

Recruiting

Atrial fibrillation (AF) is a type of irregular heart rhythm due to electrical signal disturbances of the heart. It is a very common arrhythmia and the risk of developing AF increases with age and with other risk factors such as diabetes, high blood pressure, and underlying heart disease. The main complications of AF are heart failure and stroke. However, studies have shown that restoration of normal rhythm does not reduce these complications. Rather, these complications are mitigated by control... Read More

Atrial fibrillation (AF) is a type of irregular heart rhythm due to electrical signal disturbances of the heart. It is a very common arrhythmia and the risk of developing AF increases with age and with other risk factors such as diabetes, high blood pressure, and underlying heart disease. The main complications of AF are heart failure and stroke. However, studies have shown that restoration of normal rhythm does not reduce these complications. Rather, these complications are mitigated by controlling the heart rate and using blood thinners to prevent stroke. Symptoms secondary to AF can occur due to the irregular heart rate and poor contraction in the atria, the top chambers of the heart. These symptoms include shortness of breath, fatigue, reduced exercise tolerance, and palpitations. Restoring sinus rhythm can sometimes alleviate these symptoms. Given that studies to date have not shown a difference in hard clinical endpoints between rate and rhythm control strategies, the decision to proceed with rhythm control depends on the patient symptom burden. Rhythm control strategies in patients with persistent AF include cardioversion back to sinus rhythm with long-term recurrence prevention via anti-arrhythmic drugs (AADs) or catheter ablation. However, many studies of these procedures omit a sham placebo control arm. No atrial fibrillation procedural intervention has been compared to a sham procedure. The cardioversion procedure can easily be compared to a "sham" alternative, as it is non-invasive with an expected response within days-to-weeks. Thus, a cardioversion versus "sham" cardioversion trial will allow us to truly assess the impact of a rhythm-control strategy on QOL. It is hypothesized that cardioversion of atrial fibrillation leads to significant improvement in quality of life (QOL) compared to sham cardioversion. Understanding the true QOL impact of sinus rhythm restoration in patients with persistent AF is of significant importance in guiding strategies for the management of AF. Hence, by evaluating what the true effect of cardioversion on QOL in this blinded study, we can better understand the role of medical management and AF ablation in our patients and assess resource allocation to these procedures. Read Less

Gender:

ALL

Ages:

18 years and above

Trial Updated:

05/07/2024

Locations: University of Ottawa Heart Institute, Ottawa, Ontario

Conditions: Atrial Fibrillation

Register for Updates

Learn More ›

Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation

NCT03347227

Recruiting

A multicentre, parallel group, two arm, single-blinded randomized clinical trial, assessing the efficacy of a patient-tailored catheter ablation (CA) strategy guided by atrial scar mapping in addition to pulmonary vein isolation (PVI) when compared to PVI alone in patients with persistent atrial fibrillation (AF).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

05/07/2024

Locations: Libin Cardiovascular Institute, Calgary, Alberta +14 locations

Conditions: Atrial Fibrillation

Register for Updates

Learn More ›

Exercise Training in Patients With Persistent or Permanent Atrial Fibrillation

NCT03397602

Recruiting

The main purpose of this project is to evaluate the effects of high-intensity interval training (HIIT) compared to moderate-intensity continuous exercise training (MICE) and standard care on exercise capacity and quality of life in patients with persistent or permanent atrial fibrillation. Positive findings are vitally important for these patients, given the condition's substantial morbidity, mortality and high economic costs.

Gender:

ALL

Ages:

40 years and above

Trial Updated:

05/06/2024

Locations: London Health Sciences Network, London, Ontario +1 locations

Conditions: Atrial Fibrillation

Register for Updates

Learn More ›

A Behavioural Weight Loss Intervention Delivered in Cardiac Rehabilitation for Patients With Atrial Fibrillation and Obesity

NCT05600829

Recruiting

One-in-four Canadians will be diagnosed with an abnormal heart rhythm called atrial fibrillation (AF) in their lifetime. This is expected to double by 2050, owing to an aging population and increased age- and health behaviour-associated AF risk factors (e.g., poor cardiorespiratory fitness, Type II diabetes, hypertension, and obesity). AF is associated with an increased risk of severe health outcomes including stroke, heart failure, dementia, and death. Nearly three-quarters of people with AF al... Read More

One-in-four Canadians will be diagnosed with an abnormal heart rhythm called atrial fibrillation (AF) in their lifetime. This is expected to double by 2050, owing to an aging population and increased age- and health behaviour-associated AF risk factors (e.g., poor cardiorespiratory fitness, Type II diabetes, hypertension, and obesity). AF is associated with an increased risk of severe health outcomes including stroke, heart failure, dementia, and death. Nearly three-quarters of people with AF also have obesity (excess body weight). According to research, people with obesity that lose approximately 10% of their body weight can experience relief from uncomfortable AF symptoms. Losing weight may even help people return to a normal heart rhythm. Cardiac rehabilitation (CR) is a proven way to help people with heart disease live longer, healthier lives. So far, research has not shown whether CR helps improve the abnormal heart rhythms seen in AF. This may be because CR programs usually do not offer specific help with weight management. Therefore, adding behavioural weight-loss treatment (BWLT; group classes to change thoughts and behaviours to encourage weight loss) to CR programs may help people with AF and obesity experience relief from their symptoms. This randomized controlled trial will assess whether the combination of an AF-specific 'small changes' BWLT and traditional CR results in a greater proportion of patients with AF and obesity achieving ≥ 10% body weight loss compared to patients who receive standard care (traditional CR alone). Traditional CR consists of participating in exercise sessions, supervised by health professionals, twice per week for 12 weeks. In addition to traditional CR, patients that are randomized to receive BWLT will attend 12 weekly online group therapy classes to learn strategies from psychology to help encourage weight loss. The investigators will collect data pertaining to weight, AF burden, physical activity, and disease-specific and generic patient-reported outcomes. This information will determine if taking CR+BWLT helps patients with weight loss and AF symptoms. Further, it will help efforts to provide effective treatment to patients with AF to help participants lose weight and reduce or eliminate AF symptoms. Read Less

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/23/2024

Locations: Behavioural Medicine Lab, Calgary, Alberta

Conditions: Atrial Fibrillation, Obesity

Register for Updates

Learn More ›

Pulsed Field Ablation and Pulsed Field CRyoAbLation in PErsistent AtriaL FibrilLation

NCT05408754

Recruiting

A prospective, two-arm, multi-center, randomized, open-label, pre-market, First-in-Human clinical study designed to provide safety and performance data regarding the use of the Adagio PFA and PFCA Systems in the treatment of PsAF.

Gender:

ALL

Ages:

Between 18 years and 80 years

Trial Updated:

04/23/2024

Locations: Onze-Lieve-Vrouwziekenhuis (OLV), Aalst, Not set +5 locations

Conditions: Atrial Fibrillation

Register for Updates

Learn More ›

Atrial Fibrillation Clinical Trials in Canada

Match to Clinical Trials